Snapshot
- A 40-year-old woman presents to the emergency room with a week of fever, cough, and hemoptysis. She has a history of HIV and has been noncompliant with her medications and has a history of tuberculosis that was adequately treated. She reports feeling increasing fatigue. A chest CT shows nodules with a halo sign. A bronchoalveolar lavage with biopsy eventually reveals fungus with septate hyphae branching at acute angles invading into lung tissue. (Invasive aspergillosis)
Candida albicans
- Classification
- yeast with budding and pseudohyphae
- Risk factors
- immunocompromised status
- hospital admission, especially in the ICU
- Clinical syndrome
- immunocompetent hosts present with skin and mucous membrane infections
- candidal intertrigo
- well-demarcated, erythematous, and itchy plaques in the skin folds
- candidal intertrigo
- vulvovaginitis
- thick “cottage cheese” white discharge
- itchiness
- immunocompromised hosts usually present with systemic disease
- endocarditis
- associated with IV drug users
- fevers and a new murmur
- disseminated/invasive candidiasis
- fever and septic shock
- endocarditis
- immunocompetent hosts present with skin and mucous membrane infections
- Studies
- Treatment
- nystatin
- local infections
- azoles
- local and systemic infections
- first-line if the fungus is not resistant
- echinocandins
- systemic infections
- first-line due to increased resistance to azoles
- amphotericin B
- systemic infections
- nystatin
- second-line or for pregnant women
Cryptococcus neoformans
- Classification
- urease-positive monomorphic encapsulated yeast with 5-10 μm narrow budding
- transmitted via inhalation and found in soil and pigeon droppings
- Risk factors
- immunocompromised status
- HIV/AIDS patients
- Clinical syndrome
- cryptococcal meningitis
- cryptococcal encephalitis
- presents with fevers, headaches, and generalized malaise
- Studies and imaging
- head imaging with computed tomography (CT) or magnetic resonance imaging (MRI)
- variable enhancing lesions
- hydrocephalus
- head imaging with computed tomography (CT) or magnetic resonance imaging (MRI)
- Treatment
- amphotericin B + flucytosine
- for 10-14 days
- fluconazole
- after treatment with amphotericin B and flucytosine
- amphotericin B + flucytosine
- maintenance and suppressive therapy
Aspergillus spp.
- Classification
- most commonly Aspergillus fumigatus
- monomorphic fungus with septate hyphae branching at acute angles (45 degrees)
- found in soil and decomposed material
- Risk factors
- immunocompromised status
- hematologic malignancy
- asthma
- pre-existing lung disease
- Clinical syndrome
- invasive aspergillosis
- invasive infection of the lung
- causes persistent fever and cough with hemoptysis
- aspergilloma
- mycetoma (“fungal ball”) in pre-existing cavity (i.e., tuberculosis)
- causes cough with hemoptysis or asymptomatic
- allergic bronchopulmonary aspergillosis (ABPA)
- hypersensitivity reaction in patients with cystic fibrosis or asthma
- causes bronchiectasis and eosinophilia
- causes cough with hemoptysis, brownish black mucus plugs in expectorate, and wheezing
- invasive aspergillosis
- Studies and imaging
- invasive aspergillosis
- nodules with halo sign and cavitary lesions on computed tomography (CT)
- positive cultures or serology
- invasive aspergillosis
- Treatment
- invasive aspergilloma
- voriconazole + amphotericin B
- first-line
- caspofungin
- second-line
- voriconazole + amphotericin B
- aspergilloma
- surgical resection
- ABPA
- steroids
- invasive aspergilloma
- first-line
Mucormycosis
- Classification
- Risk factors
- diabetic ketoacidosis
- immunocompromised status
- trauma or burns
- Clinical syndrome
- Studies and imaging
- Treatment
- amphotericin B
- first-line
- isavuconazole
- second-line
- surgical debridement
- amphotericin B
- for patients who need it, in addition to antifungals
Pneumocystis jiroveci
- Classification
- a yeast-like fungus
- transmission via airborne
- Risk factors
- immunocompromised status (e.g., hyper IgM syndrome)
- HIV
- smoking
- Clinical syndrome
- Imaging
- computed tomography will show patchy ground-glass opacities sand pneumatoceles
- Studies
- Treatment
- trimethoprim-sulfamethoxazole (TMP-SMX)
- prophylaxis (CD4+ count < 200 cells/mm3) and first-line therapy
- corticosteroids
- severe cases
- pentamidine, atovaquone, or dapsone
- second-line therapy if resistant to TMP-SMX or allergic
- trimethoprim-sulfamethoxazole (TMP-SMX)